Your browser doesn't support javascript.
loading
Two-year efficacy and safety of erenumab in participants with episodic migraine and 2-4 prior preventive treatment failures: results from the LIBERTY study.
Ferrari, Michel Dominique; Reuter, Uwe; Goadsby, Peter J; Paiva da Silva Lima, Gabriel; Mondal, Subhayan; Wen, Shihua; Tenenbaum, Nadia; Pandhi, Shaloo; Lanteri-Minet, Michel; Stites, Tracy.
Afiliación
  • Ferrari MD; Department of Neurology, Leiden University Medical Center, 2300 RC Leiden, Netherlands m.d.ferrari@lumc.nl.
  • Reuter U; Department of Neurology, Charite Universitatsmedizin Berlin, Berlin, Germany.
  • Goadsby PJ; Universitätsmedizin Greifswald, Greifswald, Mecklenburg-Vorpommern, Germany.
  • Paiva da Silva Lima G; NIHR-Wellcome Trust King's Clinical Research Facility, King's College London, London, UK.
  • Mondal S; Department of Neurology, University of California Los Angeles, Los Angeles, California, USA.
  • Wen S; Amgen Inc, Thousand Oaks, California, USA.
  • Tenenbaum N; Biostatistics and Pharmacometrics, Novartis Healthcare Pvt Ltd, Hyderabad, India.
  • Pandhi S; Novartis Pharmaceuticals Corp, East Hanover, New Jersey, USA.
  • Lanteri-Minet M; Novartis Pharmaceuticals Corp, East Hanover, New Jersey, USA.
  • Stites T; Novartis Pharma AG, Basel, Basel-Stadt, Switzerland.
J Neurol Neurosurg Psychiatry ; 93(3): 254-262, 2022 03.
Article en En | MEDLINE | ID: mdl-34845002
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Monoclonales Humanizados / Antagonistas del Receptor Peptídico Relacionado con el Gen de la Calcitonina / Trastornos Migrañosos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurol Neurosurg Psychiatry Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Monoclonales Humanizados / Antagonistas del Receptor Peptídico Relacionado con el Gen de la Calcitonina / Trastornos Migrañosos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurol Neurosurg Psychiatry Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos